Raised FFO guidance, stronger balance sheet, and improving outpatient and lab occupancy are the call’s clearest signals.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-08-05 |
| Length | 37 minutes |
| EPS | $0.46 |
| EPS consensus | $0.44 |
| Revenue | $771.6M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q1 FY26 · Q4 FY25
All DOC earnings · Back to DOC overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.